Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Recruiting now

Conditions studied: Cardiovascular Diseases (CVD), Type 2 Diabetes, Chronic Respiratory Diseases, Obesity (Disorder), Chronic Kidney Diseases

In brief

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Key facts

Study ID

NCT06953180

Run by

Asfendiyarov Kazakh National Medical University

People needed

6720

Starts

2025-03-03

Expected to finish

2026-12-31

Last updated by the study team

2025-07-11

Who can join

Age: 18 and older, up to 69. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults aged 18 to 69 years.
• Residents of 17 regions of Kazakhstan.
• Willingness to participate and provide informed consent.

You may not qualify if…

• Age less than 18 years old or over 69 years old.
• Failure to provide informed consent or incomplete participation in data collection procedures.

Where it is running

• Asfendiyarov Kazakh National Medical University — Almaty, Kazakhstan, Kazakhstan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.